USANA Health Sciences Reports First Quarter 2026 Results
USANA reported Q1 2026 net sales of $250 million, flat compared to the prior year, but net earnings fell 20% to $7.5 million and adjusted EPS dropped 16% to $0.61. The Core Nutritional segment saw active customers decline 12% year-over-year to 404,000, though Greater China showed sequential growth. Conversely, the Rise Wellness segment generated triple-digit growth with $14 million in sales.
Key figures
- Eps
- 0.41
- Eps Beat
- 0
- Revenue
- 250218000
- Guidance
- FY2026 Consolidated net sales $925 million - $1.0 billion; Net earnings $20 million - $27 million; Diluted EPS $1.11 - $1.45; Adjusted diluted EPS $1.95 - $2.29
- Revenue Yoy
- 0.3%
- Debt
- 14000000
- Adjusted eps
- 0.61
- Net sales rise
- 13669000
- Adjusted ebitda
- 28400000
- Cash and equivalents
- 162751000
- Active customers core
- 404000
- Active subscribers hiya
- 186000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.